uploads/2017/01/clx-anr.png

How Do Analysts Rate Clorox and Its Peers?

By

Updated

Analyst coverage

Out of 15 analysts covering Clorox’s (CLX) stock, 13.0% rated the stock as a “buy,” 74.0% rated it as a “hold,” and 13.0% rated it as a “sell.” The 12-month average stock price target for Clorox is $121.55 per share, which is the same as the stock’s closing price of $121.55 on January 24. Clorox manufactures and markets consumer and professional products like cleaning products, supplies, and bleach.

Article continues below advertisement

Rating analysis

The “hold” recommendation for Clorox from 75% of analysts shows that analysts are keeping an eye on the company’s 2020 growth strategy, the impact of foreign exchange, and the impact of other macro challenges.

In December 2016, Morgan Stanley upgraded Clorox’s rating to “equal weight” from “under weight.” On January 9, Barclays upgraded the company’s stock to “equal weight” from “under weight.” Clorox constitutes 2.8% of the Guggenheim S&P 500 Equal Weight Consumer Staples ETF (RHS).

Comparison with peers

Of the 21 analysts covering Procter & Gamble (PG), 48% have rated the stock as a “buy” as of January 24. The stock is rated a “hold” by 43.0% of analysts and a “sell” by 9.0% of analysts. Analysts have set the stock’s 12-month price target at $90.53 per share with upside potential of 3.0%.

Of the 20 analysts covering Colgate-Palmolive (CL), 15.0% have rated the stock as a “buy” as of January 24. The stock was rated a “hold” by 85.0% of the analysts. Analysts have set the stock’s 12-month price target at $72.73 per share with upside potential of 7.0%.

Of the 14 analysts covering Kimberly-Clark (KMB), 14.0% rated the stock as a “buy,” 72.0% rated it as a “hold,” and 14.0% rated it as a “sell.” Analysts have set the average 12-month stock price target at $124.50 per share with upside potential of 2.0%.

We’ll discuss the company’s valuation in the concluding part of this series.

Advertisement

More From Market Realist